A daily prebiotic fiber supplement significantly reduced knee osteoarthritis pain and improved physical function in a recent clinical trial. Participants taking the supplement also showed increased grip strength and reduced pain sensitivity. This research suggests a connection between gut health, muscle function, and pain perception.
Researchers at the University of Nottingham conducted the INSPIRE clinical trial. They investigated inulin, a natural dietary fiber found in various vegetables. The study found that daily inulin intake substantially decreased pain among individuals with osteoarthritis.
The findings were published in the journal *Nutrients*. They indicate that supporting gut health could offer a new approach to managing knee osteoarthritis. This condition is a widespread cause of chronic pain and disability, particularly in older adults.
Inulin functions as a prebiotic, nourishing beneficial gut bacteria. These bacteria produce short-chain fatty acids, such as butyrate, which can influence inflammation and pain pathways. Participants receiving inulin had higher levels of butyrate and glucagon-like peptide-1 (GLP-1), a gut hormone linked to pain regulation and muscle health. Elevated GLP-1 levels correlated with improved grip strength.
The six-week randomized controlled trial involved 117 adults with knee osteoarthritis. Participants were divided into four groups: inulin alone, digital physiotherapy-supported exercise (PSE) alone, both treatments, or a placebo. Both inulin and physiotherapy independently reduced knee pain. However, only the inulin group experienced enhanced grip strength and lower pain sensitivity. The inulin group also had a significantly lower dropout rate, at 3.6%, compared to 21% in the physiotherapy group. This suggests that a daily supplement may be easier for patients to adhere to than an exercise program.
Related stories
Dreaming May Deplete Brain Energy Despite Increased Fuel Supply
New research indicates that dreaming during REM sleep may consume significant brain energy, with neuronal energy levels dropping despite an increase in the brain's fuel supply.
Tirzepatide May Activate Calorie-Burning Brown Fat
A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, may activate calorie-burning brown fat, offering a new understanding of its metabolic benefits.
ADHD and Autism Diagnoses Show Shifting Demographics in Denmark
A large Danish study found that children diagnosed with ADHD or autism now more closely resemble the general population, suggesting broader identification rather than only an increase in underlying conditions.